Improved blood compatibility by sustained release of heparin–deoxycholic acid conjugates in a PCL–PEG multiblock copolymer matrix

The heparin and deoxycholic acid conjugate (heparin-DOCA) synthesized in this study has an amphiphilic property and could be completely dissolved in a co-solvent made of 1,4-dioxane (50 v/v%), n-propanol (25 v/v%), and water (25 v/v%). A polycaprolacton (PCL)-polyethylene glycol (PEG) multiblock copolymer was used as the coating matrix; this polymer also dissolved readily in the same co-solvent. Heparin-DOCA and the PCL-PEG multiblock copolymer were mixed well to produce a transparent coated film on an angio-catheter. The bioactivity of the released heparin-DOCA was determined by evaluating platelet adhesion and fibrin formation on the coated surfaces. The release rate could be controlled by the loading amount of the drug and drug release was maintained for 12 h. The released heparin-DOCA significantly prevented platelet adhesion and fibrin formation at the surfaces, as well as in the bulk in the plasma.

[1]  Y. Bae,et al.  Biodegradable amphiphilic multiblock copolymers and their implications for biomedical applications. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[2]  Y. Byun,et al.  Preparation of slightly hydrophobic heparin derivatives which can be used for solvent casting in polymeric formulation. , 1998, Thrombosis research.

[3]  E. Mathiowitz,et al.  Controlled delivery of therapeutics from microporous membranes. II. In vitro degradation and release of heparin-loaded poly(D,L-lactide-co-glycolide). , 1997, Biomaterials.

[4]  D. Waters,et al.  Local delivery of heparin to balloon angioplasty sites with a new angiotherapy catheter: pharmacokinetics and effect on platelet deposition in the porcine model. , 1997, Catheterization and cardiovascular diagnosis.

[5]  T. Chandy,et al.  Development of chitosan/polyethylene vinyl acetate co-matrix: controlled release of aspirin-heparin for preventing cardiovascular thrombosis. , 1997, Biomaterials.

[6]  E. Edelman,et al.  Contrasting Effects of the Intermittent and Continuous Administration of Heparin in Experimental Restenosis , 1994, Circulation.

[7]  A. Bantjes,et al.  Poly(vinyl alcohol)-heparin hydrogels as sensor catheter membranes. , 1991, Biomaterials.

[8]  K. Imai,et al.  Binding of heparin onto ethylene-vinyl alcohol copolymer membrane. , 1988, Journal of biomedical materials research.

[9]  T. Okano,et al.  Heparin immobilization onto segmented polyurethane-urea surfaces--effect of hydrophilic spacers. , 1988, Journal of biomedical materials research.

[10]  B. Casu,et al.  Structure and biological activity of heparin. , 1985, Advances in carbohydrate chemistry and biochemistry.

[11]  R. Rosenberg,et al.  Anticoagulant Action of Heparin , 1973, Nature.

[12]  C. W. Cooper,et al.  Nonthrombogenic Plastic Surfaces , 1966, Science.